← Back to Analyst Consensus 
ADCT Buy
ADC Therapeutics SA
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 17, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jun 8, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Jun 4, 2026 | RBC Capital | downgrade | Outperform → Sector Perform | — | 55% |
| May 5, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| May 5, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 23, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Oct 16, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Aug 13, 2025 | Guggenheim | reiterate | Buy → Buy | $10 | 52% |
| Jun 20, 2025 | RBC Capital | maintain | Outperform → Outperform | $5 | 55% |
| Jun 13, 2025 | Guggenheim | maintain | Buy → Buy | $10 | 52% |
| May 15, 2025 | RBC Capital | reiterate | Outperform → Outperform | $8 | 55% |
| Mar 31, 2025 | Guggenheim | maintain | Buy → Buy | $7 | 52% |
| Mar 31, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Mar 7, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Feb 24, 2025 | Stephens & Co. | maintain | Overweight → Overweight | $8 | 54% |
| Jan 6, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Dec 12, 2024 | Guggenheim | reiterate | Buy → Buy | $10 | 52% |
| Dec 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $0 | 44% |
| Nov 8, 2024 | Stephens & Co. | initiate | — → Overweight | $6 | 54% |
| Aug 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Aug 7, 2024 | RBC Capital | reiterate | Outperform → Outperform | $8 | 55% |
| May 30, 2024 | Cantor Fitzgerald | initiate | — → Overweight | $0 | 50% |
| May 7, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $8 | 44% |
| Apr 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Apr 5, 2024 | Guggenheim | reiterate | — → Buy | $0 | 52% |
| Mar 28, 2024 | Guggenheim | initiate | — → Buy | $11 | 52% |
| Mar 14, 2024 | RBC Capital | reiterate | Outperform → Outperform | $8 | 55% |
| Mar 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Feb 26, 2024 | RBC Capital | maintain | Outperform → Outperform | $8 | 55% |
| Feb 20, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $9 | 44% |
| Nov 20, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $3 | 44% |
| Nov 9, 2023 | TD Cowen | downgrade | Outperform → Market Perform | $0 | 54% |
| Nov 8, 2023 | RBC Capital | maintain | Outperform → Outperform | $6 | 55% |
| Sep 19, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Sep 12, 2023 | RBC Capital | maintain | Outperform → Outperform | $8 | 55% |
| Aug 10, 2023 | JP Morgan | upgrade | Underweight → Neutral | $0 | 54% |
| Aug 9, 2023 | RBC Capital | maintain | Outperform → Outperform | $9 | 55% |
| Jul 25, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Jul 11, 2023 | Morgan Stanley | reiterate | Equal-Weight → Equal-Weight | $2 | 54% |
| Jun 20, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| May 10, 2023 | RBC Capital | maintain | — → Outperform | $10 | 55% |
| Apr 24, 2023 | B of A Securities | downgrade | Neutral → Underperform | $2 | 53% |
| Feb 13, 2023 | RBC Capital | maintain | — → Outperform | $12 | 55% |
| Jan 24, 2023 | Morgan Stanley | maintain | — → Equal-Weight | $5 | 54% |
| Jan 4, 2023 | HC Wainwright & Co. | maintain | — → Buy | $20 | 44% |
| Nov 14, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $7 | 54% |
| Nov 9, 2022 | RBC Capital | maintain | — → Outperform | $20 | 55% |
| Nov 9, 2022 | B of A Securities | downgrade | Buy → Neutral | $7 | 53% |
| Sep 21, 2022 | JP Morgan | initiate | — → Overweight | $5 | 54% |
| Sep 19, 2022 | HC Wainwright & Co. | maintain | — → Buy | $21 | 44% |
Price Target Trend
Apr 3, 2026 Oct 26, 2026
EPS Estimates
0y —
0q —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days